Atlas of rheumatoid arthritis / Paul Emery, editor.
Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide c...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | |
| Format: | eBook |
| Language: | English |
| Published: |
London :
Springer Healthcare,
[2015]
|
| Subjects: |
MARC
| LEADER | 00000cam a2200000xi 4500 | ||
|---|---|---|---|
| 001 | b8068998 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 150611t20152015enka ob 000 0 eng d | ||
| 005 | 20240423171400.5 | ||
| 019 | |a 914151025 |a 914289856 |a 972002511 | ||
| 020 | |a 9781907673917 |q electronic bk | ||
| 020 | |a 1907673911 |q electronic bk | ||
| 020 | |z 9781907673900 | ||
| 020 | |z 1907673903 | ||
| 024 | 7 | |a 10.1007/978-1-907673-91-7 | |
| 035 | |a (OCoLC)spr910935532 | ||
| 035 | |a (OCoLC)910935532 |z (OCoLC)914151025 |z (OCoLC)914289856 |z (OCoLC)972002511 | ||
| 035 | |a (OCoLC)910935532 |z (OCoLC)914151025 |z (OCoLC)914289856 | ||
| 037 | |a spr10.1007/978-1-907673-91-7 | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d GW5XE |d EBLCP |d YDXCP |d VLB |d UPM |d AZU |d OCLCF |d COO |d CAUOI |d IAO |d IAS |d JBG |d IAD |d ICN |d SOI |d ILO |d LVT | ||
| 049 | |a GWRE | ||
| 050 | 4 | |a RC933 |b .A84 2015eb | |
| 245 | 0 | 0 | |a Atlas of rheumatoid arthritis / |c Paul Emery, editor. |
| 264 | 1 | |a London : |b Springer Healthcare, |c [2015] | |
| 264 | 4 | |c ©2015. | |
| 300 | |a 1 online resource : |b illustrations (mostly color) | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a PART ONE Rheumatoid arthritis overview; 1 Classification ofrheumatoid arthritis; References; 2 Pre- rheumatoid arthritis; What is pre-rheumatoid arthritis?; Risk factors for rheumatoid arthritis; Systemic autoimmunity associated with rheumatoid arthritis; Symptoms without clinical arthritis; Unclassified arthritis; References; 3 Early rheumatoid arthritis; Introduction; Pathology in early rheumatoid arthritis; Diagnosis of early rheumatoid arthritis; Classification of rheumatoid arthritis; Management of early rheumatoid arthritis. | |
| 505 | 8 | |a Recommendations for the management of early rheumatoid arthritisReferences; 4 Established rheumatoidarthritis; Introduction; Stages of established rheumatoid arthritis; Common clinical presentations; References; 5 Remission and rheumatoidarthritis ; Introduction; Defining remission; Imaging remission; Immune-mediated remission; Drug-free remission; Optimal dose reduction regimes for patients in remission; References; PART TWO Imaging of rheumatoid arthritis; 6 Magnetic resonance imaging in rheumatoid arthritis; Introduction; Technical aspects; Visualizing rheumatoid arthritis. | |
| 505 | 8 | |a Diagnosing rheumatoid arthritisMonitoring disease activity and structural damage; References; 7 Ultrasound imaging in rheumatoidarthritis; Introduction; Ultrasound and rheumatoid arthritis; Cartilage damage; Management of rheumatoid arthritis with ultrasound: diagnosis,therapeutic follow-up, remission, and flare; Conclusion; References; 8 Dual energy X-ray absorptiometry in rheumatoid arthritis; Introduction; Bone remodeling in rheumatoid arthritis; Bone damage imaging in rheumatoid arthritis; Treatment of bone loss in rheumatoid arthritis; References. | |
| 505 | 8 | |a PART THREE Treatment of rheumatoid arthritis9Methotrexate; Introduction; Historical perspective; Mechanism of action and pharmacokinetics; Dosing; Benefits; Monitoring; Side effects; References; 10 Immunotherapy; Introduction; Nonbiologic disease-modifying antirheumatic drugs; Biologic disease-modifying antirheumatic drugs; Cost-effectiveness of immunotherapy in early rheumatoid arthritis; Recommendations for the use of disease-modifying antirheumaticdrug therapies; Safety of immunotherapy; Prospective new targets for immunotherapy; References; 11 Rituximab. | |
| 505 | 8 | |a B-cell development and differentiationEfficacy of rituximab in rheumatoid arthritis; 12 Novel therapies in rheumatoidarthritis: small molecules; Introduction; Inhibiting intracellular signaling pathways; Conclusion; References. | |
| 520 | |a Atlas of Rheumatoid Arthritis is a high-quality educational initiative, written by leaders in the field of rheumatology, containing a collection of approximately 150 relevant images, with extended descriptive captions and a comprehensive bibliography. The Atlas of Rheumatoid Arthritis will provide clinicians with a visual guide to rheumatoid arthritis, focusing on assessment, diagnosis and treatment, including newer research into the signalling pathways involved in the pathogenesis of RA, before focusing on the treatment of RA. Rheumatoid arthritis (RA) is the most common and most serious of t. | ||
| 588 | 0 | |a Online resource; title from PDF title page (Ebsco, viewed June 10, 2015) | |
| 650 | 0 | |a Rheumatoid arthritis. |0 http://id.loc.gov/authorities/subjects/sh85113649. | |
| 650 | 0 | |a Rheumatoid arthritis |x Diagnosis. | |
| 650 | 0 | |a Rheumatoid arthritis |x Treatment. | |
| 650 | 0 | |a Joints |v Atlases. | |
| 650 | 7 | |a Joints. |2 fast |0 (OCoLC)fst00983905. | |
| 650 | 7 | |a Rheumatoid arthritis. |2 fast |0 (OCoLC)fst01097027. | |
| 650 | 7 | |a Rheumatoid arthritis |x Diagnosis. |2 fast |0 (OCoLC)fst01097031. | |
| 650 | 7 | |a Rheumatoid arthritis |x Treatment. |2 fast |0 (OCoLC)fst01097041. | |
| 655 | 7 | |a Atlases. |2 fast |0 (OCoLC)fst01423875. | |
| 700 | 1 | |a Emery, Paul, |e editor. |0 http://id.loc.gov/authorities/names/n2001127725 |1 http://isni.org/isni/0000000032324270. | |
| 776 | 0 | 8 | |i Print version: |a Emery, P. |t Atlas of rheumatoid arthritis |z 9781907673900 |w (OCoLC)910840977. |
| 856 | 4 | 0 | |u https://colorado.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-1-907673-91-7 |z Full Text (via Springer) |
| 907 | |a .b8068998x |b 03-19-20 |c 08-04-15 | ||
| 998 | |a web |b 07-01-17 |c g |d b |e - |f eng |g enk |h 0 |i 1 | ||
| 907 | |a .b8068998x |b 07-02-19 |c 08-04-15 | ||
| 944 | |a MARS - RDA ENRICHED | ||
| 907 | |a .b8068998x |b 01-17-18 |c 08-04-15 | ||
| 907 | |a .b8068998x |b 07-06-17 |c 08-04-15 | ||
| 907 | |a .b8068998x |b 05-23-17 |c 08-04-15 | ||
| 915 | |a I | ||
| 956 | |a Springer e-books | ||
| 956 | |b Springer Nature - Springer Medicine eBooks 2015 English International | ||
| 956 | |b Springer Nature - Springer Medicine eBooks 2015 English International | ||
| 999 | f | f | |i c3b82c72-7f0a-57a4-bf83-869c53b4471d |s 4f4a50ec-6837-5655-8ef0-a9fca542d99e |
| 952 | f | f | |p Can circulate |a University of Colorado Boulder |b Online |c Online |d Online |e RC933 .A84 2015eb |h Library of Congress classification |i Ebooks, Prospector |n 1 |